BACE1 and Alzheimer disease: However, experiments reveal that neither overexpressing nor knocking down ELK1 affects the mRNA levels of APP, BACE1 or PS1 in AD model cells because ELK1 could not bind to their promoters (Supplementary Fig. 3).